To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast Cancer

Exclusion Criteria

• •1. Patient previously treated with chemotherapy for breast cancer
• •2. Patient with metastatic breast cancer
• •3. History of psychiatric illness or treatment with neuroleptics, antidepressants or thymoregulators thymoregulator, prior to discovery of cancer (except resolved depressive episode, without psychiatric treatment for at least 2 years). An anxiolytic or hypnotic treatment prescribed after diagnosis is authorized
• •4. Patient suffering from psychiatric disorders, delusional phases, schizophrenia contraindicating practice of sophrology
• •5. Patient who has already had an introduction to sophrology in the context of her pathology, or who plans to start sophrology within within 3 months of the start of treatment outside the hospital structure and by her own means
• •6. Patient does not understand or speak French
• •7. Cognitive impairment or inability to understand, compromising participation in the study and use and understanding of the device
• •8. Patient under legal protection, guardianship or trusteeship
• •9. Inability to undergo protocol monitoring for geographical or social reasons.
• •10. Patient participating in another interventional study evaluating supportive care